Cardlytics (CDLX) Equity Average (2017 - 2026)

Cardlytics has reported Equity Average for 10 years, with the latest figure at -$5.3 million in Q1 2026.

• For the quarter ending Q1 2026, Equity Average fell 107.84% year-over-year to -$5.3 million; the trailing twelve-month figure through Mar 2026 stood at -$5.3 million (down 107.84% YoY), and the FY2025 full-year result was $31.7 million, down 69.0% from the prior year.
• Equity Average for Q1 2026 stood at -$5.3 million, up from -$5.6 million in the prior quarter.
• The five-year high for Equity Average was $701.2 million in Q1 2022, with the low at -$5.6 million in Q4 2025.
• Historically, Equity Average has averaged $229.4 million across 5 years, with a median of $180.1 million in 2023.
• Annual changes were most pronounced in 2022 — Equity Average jumped 55.46% — and 2025, when it plunged 108.03%.
• Cardlytics' Equity Average stood at $396.1 million in 2022, then slumped by 54.54% to $180.1 million in 2023, then plunged by 61.21% to $69.8 million in 2024, then plunged by 108.03% to -$5.6 million in 2025, then advanced by 6.25% to -$5.3 million in 2026.
• The last three Equity Average figures came in at -$5.3 million (Q1 2026), -$5.6 million (Q4 2025), and $27.0 million (Q3 2025), per Business Quant data.